GO
Loading...

New Jersey

More

  • Wyndham 3Q adjusted profit tops Wall Street's view Friday, 24 Oct 2014 | 6:39 AM ET

    PARSIPPANY, N.J.— Wyndham Worldwide Corp.' s third-quarter net income rose 10 percent as revenue improved across all business segments. Wyndham earned $206 million, or $1.64 per share, for the period ended Sept. 30. Revenue climbed to $1.51 billion from $1.43 billion, but fell slightly short of Zacks' forecast for $1.52 billion in revenue.

  • IGI Labs beats Street 3Q forecasts Thursday, 23 Oct 2014 | 7:48 PM ET

    BUENA, N.J. _ IGI Laboratories Inc. on Thursday reported a third-quarter loss of $202,000. The average estimate of analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share. Analysts expected $6.3 million, according to Zacks.

  • APNewsBreak: Icahn says Taj casino likely to close Thursday, 23 Oct 2014 | 6:10 PM ET

    ATLANTIC CITY, N.J.— Billionaire investor Carl Icahn says the struggling Trump Taj Mahal casino "will almost certainly close." Four of Atlantic City's 12 casinos have closed this year, and the Taj Mahal would be the fifth. Icahn, sounding very much like a man growing tired of the whole topic, said that even though he won't back out of a deal he made with owner Trump...

  • NPS Pharma says FDA extends review of Natpara Thursday, 23 Oct 2014 | 5:13 PM ET

    NEW YORK— NPS Pharmaceuticals says the Food and Drug Administration won't make a decision on its drug Natpara on Friday and will extend its review by three months. The company said Thursday that the FDA is now scheduled to make a decision on Natpara by Jan. 24. Shares of NPS Pharmaceuticals Inc. shed $1.08, or 3.7 percent, to $28 in aftermarket trading.

  • Chubb beats Street 3Q forecasts Thursday, 23 Oct 2014 | 4:27 PM ET

    WARREN, N.J. _ Chubb Corp. on Thursday reported earnings of $594.3 million in its third quarter. Analysts expected $3.37 billion, according to Zacks. For the current quarter ending in December, Chubb expects its per-share earnings to range from $2 to $2.10.

  • *Saudi Arabia increases Sept output but cuts market supply. *All eyes on OPEC November meeting. NEW YORK, Oct 23- Brent crude oil jumped nearly 3 percent on Thursday, its most in over four months, after an industry source said Saudi Arabia cut output in September following the summer's tumble in prices.

  • Tax trial for 'The Situation' set for December Thursday, 23 Oct 2014 | 1:08 PM ET

    NEWARK, N.J.— A judge has scheduled a December trial for a former cast member of MTV's reality show "Jersey Shore" who's facing federal tax charges. Mike "The Situation" Sorrentino and his brother, Marc, appeared in court Thursday in Newark, New Jersey. Mike Sorrentino was initially scheduled for arraignment two weeks ago but was given an extension because he was...

  • UPDATE 6-Brent jumps on Saudi supply cut, strong data Thursday, 23 Oct 2014 | 12:45 PM ET

    *Saudi Arabia increases Sept output but cuts market supply. *All eyes on OPEC November meeting. NEW YORK, Oct 23- Brent crude oil jumped as much as $2 a barrel on Thursday after an industry source said Saudi Arabia cut output in September following the summer's tumble in prices.

  • NJ Turnpike widening set to ease bottleneck Thursday, 23 Oct 2014 | 11:37 AM ET

    TRENTON, N.J.— One of New Jersey's most notorious traffic bottlenecks may soon disappear. A $2.3 billion project to widen the New Jersey Turnpike from six to 12 lanes between Interchange 6, in Burlington County, and Interchange 9, in New Brunswick, is nearly complete. Thomas Feeney, a turnpike authority spokesman, said the project came in more than $200 million...

  • Taj Mahal casino workers dreading insurance loss Thursday, 23 Oct 2014 | 11:30 AM ET

    ATLANTIC CITY, N.J.— One worker had to move up a double mastectomy before her insurance runs out in a week. All three are longtime workers at Atlantic City's Taj Mahal casino, and in just over a week, the three will be without health insurance following a judge's termination of the union's contract with the bankrupt casino. When U.S. Bankruptcy Court Judge Kevin Gross...

  • Mack-Cali reports 3Q results Thursday, 23 Oct 2014 | 8:28 AM ET

    EDISON, N.J. _ Mack-Cali Realty Corp. on Thursday reported a key measure of profitability in its third quarter. The average estimate of analysts surveyed by Zacks Investment Research was for funds from operations of 47 cents per share. Analysts expected $152.7 million, according to Zacks.

  • Celgene 3Q profit climbs; company lifts outlook Thursday, 23 Oct 2014 | 7:54 AM ET

    NEW YORK— Celgene Corp. said Thursday that its net income climbed 37 percent in the third quarter, and the biotechnology company raised its forecast for the full year. Celgene also announced a new cancer drug development partnership with a price tag that could top $1 billion. Excluding one-time items Celgene said it earned 97 cents per share.

  • Quest Diagnostics beats Street 3Q forecasts Thursday, 23 Oct 2014 | 7:13 AM ET

    MADISON, N.J. _ Quest Diagnostics Inc. on Thursday reported profit of $129 million in its third quarter. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $1.08 per share. Quest Diagnostics expects full-year earnings in the range of $4.03 to $4.07 per share.

  • Covanta beats 3Q earnings expectations Wednesday, 22 Oct 2014 | 6:39 PM ET

    MORRISTOWN, N.J. _ Covanta Holding Corp. on Wednesday reported net income of $6 million in its third quarter. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 21 cents per share. Covanta expects full-year earnings in the range of 35 cents to 50 cents per share.

  • Owners: Taj Mahal to stay open throughout November Wednesday, 22 Oct 2014 | 5:38 PM ET

    ATLANTIC CITY, N.J.— Trump Entertainment Resorts is dropping its threat to close Atlantic City's Taj Mahal casino on Nov. 13. Trump Entertainment has been pursuing a long-shot rescue plan to re-finance the company and transfer ownership to billionaire Carl Icahn, who would pump $100 million into it. "As of now we don't have any plan to close the Taj, but that could...

  • C.R. Bard beats Street 3Q forecasts Wednesday, 22 Oct 2014 | 4:18 PM ET

    MURRAY HILL, N.J. _ C.R. Bard Inc. on Wednesday reported net income of $131.3 million in its third quarter. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $2.10 per share. Analysts expected $817.8 million, according to Zacks.

  • Oct 22- A consortium of buyout firms Advent International Corp and Avista Capital Partners is in advanced talks to acquire UCB SA's U.S. generic drugs unit Kremers Urban Pharmaceuticals Inc, according to people familiar with the matter. Advent and Avista have prevailed in an auction for Kremers Urban, which attracted interest from other private equity firms...

  • Caesars' CEO hails center, fate of casinos cloudy Wednesday, 22 Oct 2014 | 2:54 PM ET

    ATLANTIC CITY, N.J.— The CEO of Caesars Entertainment said Wednesday a new $125 million meeting center his company is building will help define Atlantic City's future, even as he pointedly refused to say whether his company is done closing casinos there. Gary Loveman said the center next to Harrah's Resort Atlantic City will be ready by next summer and should...

  • A Republican Senate means changing the chairmen Wednesday, 22 Oct 2014 | 1:58 PM ET

    WASHINGTON— If Republicans win the Senate, the Pentagon should brace for constant grilling from Sen. The size of a Republican majority would determine committee ratios and budgets; more seats in the Senate translate into a greater advantage on the panels. "If we lose the Senate, for one thing, the way this Senate's been operating, they could end up blocking all my...

  • Johnson & Johnson plans Ebola vaccine testing Wednesday, 22 Oct 2014 | 7:42 AM ET

    NEW BRUNSWICK, N.J.— Johnson& Johnson will begin safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. Johnson& Johnson also plans to test whether its vaccine protects against the version causing the outbreak, which has killed more than 4,500 people. Johnson& Johnson is developing the vaccine...